Finzati - Logo
ELV logo

Elevance Health Inc.

ELV • Medical - Healthcare Plans
$407.50
▼ -7.28 (-1.76%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$90.37B
Growth
11.0%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 12.1%Positive free cash flow · 14.31Consistent free cash flow · 5/5Reasonable earnings multiple · 13.73Manageable debt level · 0.76
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 22, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$407.50
Change-1.76%
Shares Out220.40M
Market Cap$90.37B
Enterprise Value$86.65B
52W Range273.71 - 436.24
Beta0.68
P/E17.24
P/S0.45
P/B2.06
P/FCF14.01
EV/Sales0.43

Investment DNA

How strong this company looks for long-term investors

62
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
72/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
82/100
Why this score▼
Positive revenue growth · 12.1%Positive free cash flow · 14.31Consistent free cash flow · 5/5Reasonable earnings multiple · 13.73Manageable debt level · 0.76Weak profitability

Analyst view

Analyst sentiment and price target

ELV
Analyst sentiment
Based on 38 analyst votes · 2026-09-04
86/100
Bullish
Bullish
27
Hold
11
Bearish
0
Price Target
2026-07-17
Low
$364.00
Mean
$438.44
Median
$452.50
High
$498.00

Company Overview

IPO: 10/30/2001
Industry: Medical - Healthcare Plans
P/B i: 2.06
Debt / Equity i: 0.76
Operating Margin: 4.07%
Net Margin: 2.84%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.76
Current Ratio: 1.24
Quick Ratio: 1.24
Status: Good

Insider Transactions

Recent executive and insider activity

Penczek Ronald W
Transaction: 06/12/2026
SELL
Change
-369
Price
$403.16
Filing
06/15/2026
Type
SELL
Dixon Robert L JR
Transaction: 06/11/2026
SELL
Change
-151
Price
$401.77
Filing
06/12/2026
Type
SELL
Penczek Ronald W
Transaction: 05/19/2026
SELL
Change
-877
Price
$311.48
Filing
05/20/2026
Type
SELL